Peripheral Blood Stem Cells for T Cell-Replete Nonmyeloablative Hematopoietic Transplants Using Post-Transplant Cyclophosphamide

被引：3
|
作者：
Bashey, Asad [1 ]
机构：
[1] Northside Hosp, Blood & Marrow Transplant Program, Atlanta, GA 30342 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 05期
关键词：
BONE-MARROW-TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; ACUTE-LEUKEMIA; HIGH-RISK; PHASE-II; RELAPSE; DONORS; SURVIVAL; OUTCOMES;
D O I：
10.1016/j.bbmt.2014.03.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：598 / 599
页数：2
相关论文
共 50 条
  • [1] Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma
    Mariotti, Jacopo
    Devillier, Raynier
    Bramanti, Stefania
    Giordano, Laura
    Sarina, Barbara
    Furst, Sabine
    Granata, Angela
    Maisano, Valerio
    Pagliardini, Thomas
    De Philippis, Chiara
    Kogan, Maria
    Faucher, Catherine
    Harbi, Samia
    Chabannon, Christian
    Carlo-Stella, Carmelo
    Bouabdallah, Reda
    Santoro, Armando
    Blaise, Didier
    Castagna, Luca
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1810 - 1817
  • [2] Post-transplant cyclophosphamide: overcoming the HLA barrier to hematopoietic stem cell transplants
    Bacigalupo, Andrea
    HAEMATOLOGICA, 2022, 107 (06) : 1230 - 1231
  • [3] Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
    Bashey, Asad
    Zhang, Mei-Jie
    McCurdy, Shannon R.
    St Martin, Andrew
    Argall, Trevor
    Anasetti, Claudio
    Ciurea, Stefan O.
    Fasan, Omotayo
    Gaballa, Sameh
    Hamadani, Mehdi
    Munshi, Pashna
    Al Malki, Monzr M.
    Nakamura, Ryotaro
    O'Donnell, Paul V.
    Perales, Miguel-Angel
    Raj, Kavita
    Romee, Rizwan
    Rowley, Scott
    Rocha, Vanderson
    Salit, Rachel B.
    Solh, Melhem
    Soiffer, Robert J.
    Fuchs, Ephraim Joseph
    Eapen, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) : 3002 - +
  • [4] T Cell-Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation
    Gorgeis, Jessica
    Zhang, Xu
    Connor, Katelin
    Brown, Stacey
    Solomon, Scott R.
    Morris, Lawrence E.
    Holland, H. Kent
    Bashey, Asad
    Solh, Melhem
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1861 - 1866
  • [5] HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
    Sugita, Junichi
    Kawashima, Naomi
    Fujisaki, Tomoaki
    Kakihana, Kazuhiko
    Ota, Shuichi
    Matsuo, Keitaro
    Miyamoto, Toshihiro
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Teshima, Takanori
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1646 - 1652
  • [6] Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes
    Solh, Melhem M.
    Dickhaus, Elizabeth
    Solomon, Scott R.
    Morris, Lawrence E.
    Zhang, Xu
    Holland, H. Kent
    Bashey, Asad
    BONE MARROW TRANSPLANTATION, 2019, 54 (11) : 1756 - 1763
  • [7] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Sugita, Junichi
    Kagaya, Yusuke
    Miyamoto, Toshihiro
    Shibasaki, Yasuhiko
    Nagafuji, Koji
    Ota, Shuichi
    Furukawa, Tatsuo
    Nara, Miho
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Matsuo, Keitaro
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2019, 54 (03) : 432 - 441
  • [8] Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia
    Rocha, V
    Arcuri, L. J.
    Seber, A.
    Colturato, V
    Zecchin, V. G.
    Kuwahara, C.
    Nichele, S.
    Gouveia, R.
    Fernandes, J. F.
    Macedo, A., V
    Tavares, R.
    Daudt, L.
    De Souza, M. P.
    Darrigo-Jr, L. G.
    Villela, N. C.
    Mariano, L. C. B.
    Ginani, V. C.
    Zanette, A.
    Loth, G.
    Gomes, A. A.
    Hamerschlak, N.
    Flowers, M. E.
    Bonfim, C.
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 3042 - 3048
  • [9] Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
    Mariotti, Jacopo
    Raiola, Anna Maria
    Evangelista, Andrea
    Harbi, Samia
    Patriarca, Francesca
    Carella, Michele Angelo
    Martino, Massimo
    Risitano, Antonio
    Busca, Alessandro
    Giaccone, Luisa
    Brunello, Lucia
    Merla, Emanuela
    Savino, Lucia
    Loteta, Barbara
    Console, Giuseppe
    Fanin, Renato
    Sperotto, Alessandra
    Marano, Luana
    Marotta, Serena
    Frieri, Camilla
    Sica, Simona
    Chiusolo, Patrizia
    Chabannon, Christian
    Furst, Sabine
    Santoro, Armando
    Bacigalupo, Andrea
    Bruno, Benedetto
    Blaise, Didier
    Mavilio, Domenico
    Bramanti, Stefania
    Devillier, Raynier
    Angelucci, Emanuele
    Castagna, Luca
    BONE MARROW TRANSPLANTATION, 2022, 57 (12) : 1758 - 1764
  • [10] Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation
    Dulery, Remy
    Malard, Florent
    Brissot, Eolia
    Banet, Anne
    Sestili, Simona
    Belhocine, Ramdane
    Calabro, Martina
    van de Wyngaert, Zoe
    Bonnin, Agnes
    Ledraa, Tounes
    Legrand, Ollivier
    Labopin, Myriam
    Capderou, Elodie
    Cohen, Ariel
    Ederhy, Stephane
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1215 - 1222
12345